Jackie Walling
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Jackie Walling
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jackie Walling
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PLETHORA SOLUTIONS HOLDINGS PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member | |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Biotechnology | Director/Board Member | |
Altiris Therapeutics, Inc.
 Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director/Board Member | |
Synthego Corp.
 Synthego Corp. BiotechnologyHealth Technology Synthego Corp. provides the game changing by integrating science, engineering and software. It designs and builds software and hardware solutions for building automated smart research facilities. The company was founded Michael Dabrowski and Paul Dabrowski in 2012 and is headquartered in Redwood City, CA. | Biotechnology | General Counsel | |
Vivace Therapeutics, Inc.
 Vivace Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vivace Therapeutics, Inc. discovers and develops novel cancer drug. The company was founded by Shuang Qiao in 2014 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact LLC (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| Stanford University | College/University | Masters Business Admin Masters Business Admin | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Director of Finance/CFO | |
| VIRALYTICS LTD. | Biotechnology | Director/Board Member | |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree | |
| University of Georgia | College/University | Doctorate Degree | |
| University of Michigan | College/University | Corporate Officer/Principal | |
| Technische Universität München | College/University | Doctorate Degree | |
| University of Birmingham | College/University | Undergraduate Degree | |
Strategic Decisions Group
 Strategic Decisions Group Miscellaneous Commercial ServicesCommercial Services Strategic Decisions Group provides consulting solutions. Its solutions include business strategy, portfolio management and allocation, decision and risk analytics, and organization and decision process design. The company was founded by Ronald A. Howard in 1981 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Orphagen Pharmaceuticals
 Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| Parke, Davis & Co. LLC | Corporate Officer/Principal | ||
Oxyrane UK Ltd.
 Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member | |
| CG ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
| UNIQURE N.V. | Biotechnology | Director/Board Member | |
| 4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | General Counsel | |
| FULGENT GENETICS, INC. | Medical/Nursing Services | Director/Board Member | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
LyGenesis, Inc.
 LyGenesis, Inc. BiotechnologyHealth Technology LyGenesis, Inc. operates as a biotechnology company. It develops an organ regeneration technology platform enabling a patient's lymph nodes to be used as bioreactors to regrow functioning ectopic organs. The company is headquartered in Pittsburgh, PA. | Biotechnology | Director/Board Member | |
Virtuoso Therapeutics, Inc.
 Virtuoso Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Virtuoso Therapeutics, Inc. is an oncology-focused small molecule drug discovery and development company. The company is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Suyash Prasad Consulting LLC | Corporate Officer/Principal | ||
ImmVirX Pty Ltd.
 ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
Ocean Biomedical, Inc. (United States)
 Ocean Biomedical, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria, Jonathan Kurtis and Jack A. Elias on January 2, 20219 and is headquartered in Providence, RI. | Miscellaneous Commercial Services | Chief Executive Officer | |
Bioelectric Devices, Inc.
 Bioelectric Devices, Inc. Miscellaneous Commercial ServicesCommercial Services Bioelectric Devices, Inc. develops AI-driven bioelectronics. The CEO of the American company is Russ Potts. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
CRISP-HR Therapeutics Inc.
 CRISP-HR Therapeutics Inc. Internet Software/ServicesTechnology Services CRISP-HR Therapeutics Inc. develops a CRISPR platform to create novel therapeutics for rare diseases. The American company was founded by Chris Hackley and Richard Gavan, with Chris Hackley serving as the CEO since incorporation. | Internet Software/Services | Director/Board Member | |
AceLink Therapeutics, Inc.
 AceLink Therapeutics, Inc. BiotechnologyHealth Technology AceLink Therapeutics, Inc. is a biopharmaceutical startup founded in 2018 that focuses on developing safe and effective medicines to address genetic diseases with high unmet needs. AceLink Therapeutics is based in Newark, CA. The private company's initial focus is on developing novel therapeutics for Fabry disease and type 1 Gaucher disease. The company was founded in 2018 by Wen Chen, Marvin R. Garovoy, and Jerry Shen. Jerry Shen has been the CEO since 2018. | Biotechnology | Director/Board Member | |
| OCEAN BIOMEDICAL, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| ARIDIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PREMIER VETERINARY GROUP PLC | Agricultural Commodities/Milling | Comptroller/Controller/Auditor |
Statistik
International
| Vereinigte Staaten | 40 |
| Vereinigtes Königreich | 8 |
| Australien | 3 |
| Deutschland | 2 |
| Niederlande | 2 |
Sektoral
| Health Technology | 29 |
| Commercial Services | 9 |
| Consumer Services | 8 |
| Finance | 3 |
| Health Services | 2 |
Operativ
| Director/Board Member | 71 |
| Corporate Officer/Principal | 22 |
| Independent Dir/Board Member | 21 |
| Chief Tech/Sci/R&D Officer | 18 |
| Chairman | 11 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| William Young | 32 |
| Leonard Post | 25 |
| Joseph Klein | 24 |
| Ken Bate | 19 |
| Suyash Prasad | 11 |
| Elizabeth Ng | 10 |
| Alejandro Dorenbaum | 9 |
| David J. Ellam | 6 |
| Scott Bizily | 6 |
| Wolfgang Dummer | 5 |
| Brad Glasscock | 1 |
- Börse
- Insiders
- Jackie Walling
- Unternehmensverbindungen
